Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angiodynamics Inc (NQ: ANGO )

18.85 -0.30 (-1.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 160,872
Open 19.02
Bid (Size) 18.85 (36)
Ask (Size) 29.75 (5)
Prev. Close 19.15
Today's Range 18.54 - 19.08
52wk Range 17.56 - 32.00
Shares Outstanding 38,444,076
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AngioDynamics to Present at the UBS Global Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Present at the BofA Securities Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire

Performance

YTD
-35.36%
-35.36%
1 Month
-19.99%
-19.99%
3 Month
-9.89%
-9.89%
6 Month
-33.06%
-33.06%
1 Year
-21.36%
-21.36%

More News

Read More
AngioDynamics Posts Wider Q3 Loss On Higher Costs, Reaffirms FY22 Outlook
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More
Via Benzinga
AngioDynamics Reports Fiscal 2022 Third Quarter Financial Results; Reaffirms Fiscal Year 2022 Guidance
From AngioDynamics, Inc.
Via Business Wire
Earnings Scheduled For April 7, 2022
Via Benzinga
AngioDynamics's Earnings: A Preview
Via Benzinga
AngioDynamics's Earnings Outlook
Via Benzinga
A Preview Of AngioDynamics's Earnings
Via Benzinga
AngioDynamics to Present at the Needham Virtual Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
Via Benzinga
AngioDynamics to Report Fiscal 2022 Third Quarter Financial Results on April 7, 2022
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From AngioDynamics, Inc.
Via Business Wire
4 Stocks Insiders Are Buying
Via Benzinga
AngioDynamics Earnings Perspective: Return On Capital Employed
Via Benzinga
AngioDynamics Reports Fiscal 2022 Second Quarter Financial Results; Reaffirms Revenue Guidance; Revises Gross Margin and Adjusted EPS Guidance
From AngioDynamics, Inc.
Via Business Wire
Earnings Scheduled For January 6, 2022
Via Benzinga
AngioDynamics to Present at the Needham Virtual Growth Conference
From AngioDynamics, Inc.
Via Business Wire
The Week Ahead In Biotech (Jan. 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
Via Talk Markets
AngioDynamics to Report Fiscal 2022 Second Quarter Financial Results on January 6, 2022
From AngioDynamics, Inc.
Via Business Wire
Is This Under-the-Radar Medical Devices Stock a Buy?
Via The Motley Fool
10 Biggest Price Target Changes For Friday
Via Benzinga
51 Biggest Movers From Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 15, 2021
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.